AbCellera to Present at Upcoming Investor Conferences in March
22 Febrero 2024 - 7:15PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the following investor conferences:
- 44th Annual TD Cowen Health Care Conference on Tuesday, March
5, 2024, at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time)
- KeyBanc Capital Markets Life Sciences & MedTech Investor
Forum on Wednesday, March 20, 2024, at 8:15 a.m. Pacific Time
(11:15 a.m. Eastern Time)
Live audio webcasts of each presentation may be accessed through
links that will be posted on AbCellera's Investor Relations
website. Replays of each webcast will be available through the same
links following the presentations.
About AbCellera Biologics Inc. AbCellera is breaking the
barriers of conventional antibody discovery to bring better
medicines to patients, sooner. AbCellera’s engine integrates expert
teams, technology, and facilities with the data science and
automation needed to propel antibody-based medicines from target to
clinic in nearly every therapeutic area with precision and speed.
AbCellera provides innovative biotechs and leading pharmaceutical
companies with a competitive advantage that empowers them to move
quickly, reduce cost, and tackle the toughest problems in drug
development. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221998933/en/
Inquiries Media: Kathleen Reid; media@abcellera.com,
+1(604)724-1242 Business Development: Murray McCutcheon, Ph.D.;
bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie
Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
